But in 1996, at a meeting in San Francisco, Eng arrived and set up a scientific poster he carried around showing the effects of exendin-4 in diabetic mice
[00:34:59] Emily Field: The second group is people who are already on GLP one medication
I first heard about berberine from a functional medicine doctor at a conference a decade ago
At the end of the 20th century, endocrinologist Daniel Drucker was looking for a hormone similar enough to the human gut's GLP-1, which would have similar appetite-suppressing and blood sugar-regulating qualities, without being broken down by the human body so quickly
doi: 10.1089/tmj.2014.9981
This strongly suggests that the Biden team was not up to speed on GLP-1s in the first place, and was instead myopically focused on all things Ozempic (the name frequently used in the media when referring to semaglutide for weight loss, though this is actually the drugs brand name for its type 2 diabetes indication)